Bristol-Myers Squibb Company (BIT:1BMY)

Italy flag Italy · Delayed Price · Currency is EUR
46.04
-0.68 (-1.46%)
Last updated: Jan 21, 2026, 4:34 PM CET
-14.76%
Market Cap94.86B
Revenue (ttm)40.94B
Net Income (ttm)5.15B
Shares Outn/a
EPS (ttm)2.53
PE Ratio18.43
Forward PE9.26
Dividend2.22 (4.74%)
Ex-Dividend DateOct 2, 2025
Volume91
Average Volume413
Open46.52
Previous Close46.73
Day's Range45.84 - 46.52
52-Week Range36.68 - 56.61
Betan/a
RSI48.80
Earnings DateFeb 5, 2026

About BIT:1BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Borsa Italiana
Ticker Symbol 1BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements